symbol,statement_type,period_end,line_item,value
DIACABS.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
DIACABS.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.3
DIACABS.NS,income,2025-03-31 00:00:00,Normalized EBITDA,673336000.0
DIACABS.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
DIACABS.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
DIACABS.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,344977000.0
DIACABS.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,202773000.0
DIACABS.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,9399411000.0
DIACABS.NS,income,2025-03-31 00:00:00,EBITDA,673336000.0
DIACABS.NS,income,2025-03-31 00:00:00,EBIT,470563000.0
DIACABS.NS,income,2025-03-31 00:00:00,Net Interest Income,-126443000.0
DIACABS.NS,income,2025-03-31 00:00:00,Interest Expense,126443000.0
DIACABS.NS,income,2025-03-31 00:00:00,Interest Income,
DIACABS.NS,income,2025-03-31 00:00:00,Normalized Income,344977000.0
DIACABS.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,344977000.0
DIACABS.NS,income,2025-03-31 00:00:00,Total Expenses,10688919000.0
DIACABS.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
DIACABS.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
DIACABS.NS,income,2025-03-31 00:00:00,Basic Average Shares,
DIACABS.NS,income,2025-03-31 00:00:00,Diluted EPS,
DIACABS.NS,income,2025-03-31 00:00:00,Basic EPS,
DIACABS.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,344977000.0
DIACABS.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,344977000.0
DIACABS.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
DIACABS.NS,income,2025-03-31 00:00:00,Net Income,344977000.0
DIACABS.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,344977000.0
DIACABS.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,344977000.0
DIACABS.NS,income,2025-03-31 00:00:00,Tax Provision,-857000.0
DIACABS.NS,income,2025-03-31 00:00:00,Pretax Income,344120000.0
DIACABS.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,5557000.0
DIACABS.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
DIACABS.NS,income,2025-03-31 00:00:00,Other Special Charges,
DIACABS.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-126443000.0
DIACABS.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
DIACABS.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,126443000.0
DIACABS.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
DIACABS.NS,income,2025-03-31 00:00:00,Operating Income,465006000.0
DIACABS.NS,income,2025-03-31 00:00:00,Operating Expense,1289508000.0
DIACABS.NS,income,2025-03-31 00:00:00,Other Operating Expenses,948766000.0
DIACABS.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,202773000.0
DIACABS.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,202773000.0
DIACABS.NS,income,2025-03-31 00:00:00,Selling General And Administration,
DIACABS.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
DIACABS.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
DIACABS.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
DIACABS.NS,income,2025-03-31 00:00:00,Gross Profit,1754514000.0
DIACABS.NS,income,2025-03-31 00:00:00,Cost Of Revenue,9399411000.0
DIACABS.NS,income,2025-03-31 00:00:00,Total Revenue,11153925000.0
DIACABS.NS,income,2025-03-31 00:00:00,Operating Revenue,11153925000.0
DIACABS.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-907500.0
DIACABS.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.3
DIACABS.NS,income,2024-03-31 00:00:00,Normalized EBITDA,434811000.0
DIACABS.NS,income,2024-03-31 00:00:00,Total Unusual Items,-3025000.0
DIACABS.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-3025000.0
DIACABS.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,170250000.0
DIACABS.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,195627000.0
DIACABS.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,2504786000.0
DIACABS.NS,income,2024-03-31 00:00:00,EBITDA,431786000.0
DIACABS.NS,income,2024-03-31 00:00:00,EBIT,236159000.0
DIACABS.NS,income,2024-03-31 00:00:00,Net Interest Income,-67122000.0
DIACABS.NS,income,2024-03-31 00:00:00,Interest Expense,67122000.0
DIACABS.NS,income,2024-03-31 00:00:00,Interest Income,5177000.0
DIACABS.NS,income,2024-03-31 00:00:00,Normalized Income,172367500.0
DIACABS.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,170250000.0
DIACABS.NS,income,2024-03-31 00:00:00,Total Expenses,3202016000.0
DIACABS.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,
DIACABS.NS,income,2024-03-31 00:00:00,Diluted Average Shares,532031250.0
DIACABS.NS,income,2024-03-31 00:00:00,Basic Average Shares,532031250.0
DIACABS.NS,income,2024-03-31 00:00:00,Diluted EPS,0.32
DIACABS.NS,income,2024-03-31 00:00:00,Basic EPS,0.32
DIACABS.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,170250000.0
DIACABS.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,170250000.0
DIACABS.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
DIACABS.NS,income,2024-03-31 00:00:00,Net Income,170250000.0
DIACABS.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,170250000.0
DIACABS.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,170250000.0
DIACABS.NS,income,2024-03-31 00:00:00,Tax Provision,-1213000.0
DIACABS.NS,income,2024-03-31 00:00:00,Pretax Income,169037000.0
DIACABS.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,7490000.0
DIACABS.NS,income,2024-03-31 00:00:00,Special Income Charges,-3025000.0
DIACABS.NS,income,2024-03-31 00:00:00,Other Special Charges,3025000.0
DIACABS.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-67122000.0
DIACABS.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,3135000.0
DIACABS.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,67122000.0
DIACABS.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,5177000.0
DIACABS.NS,income,2024-03-31 00:00:00,Operating Income,231694000.0
DIACABS.NS,income,2024-03-31 00:00:00,Operating Expense,697230000.0
DIACABS.NS,income,2024-03-31 00:00:00,Other Operating Expenses,422176000.0
DIACABS.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,195627000.0
DIACABS.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,195627000.0
DIACABS.NS,income,2024-03-31 00:00:00,Selling General And Administration,176454000.0
DIACABS.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,68001000.0
DIACABS.NS,income,2024-03-31 00:00:00,General And Administrative Expense,108453000.0
DIACABS.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,
DIACABS.NS,income,2024-03-31 00:00:00,Gross Profit,928924000.0
DIACABS.NS,income,2024-03-31 00:00:00,Cost Of Revenue,2504786000.0
DIACABS.NS,income,2024-03-31 00:00:00,Total Revenue,3433710000.0
DIACABS.NS,income,2024-03-31 00:00:00,Operating Revenue,3433710000.0
DIACABS.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
DIACABS.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.0
DIACABS.NS,income,2023-03-31 00:00:00,Normalized EBITDA,-234379000.0
DIACABS.NS,income,2023-03-31 00:00:00,Total Unusual Items,0.0
DIACABS.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
DIACABS.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,188369000.0
DIACABS.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,246821000.0
DIACABS.NS,income,2023-03-31 00:00:00,EBITDA,-234379000.0
DIACABS.NS,income,2023-03-31 00:00:00,EBIT,-422748000.0
DIACABS.NS,income,2023-03-31 00:00:00,Net Interest Income,-4054000.0
DIACABS.NS,income,2023-03-31 00:00:00,Interest Expense,6039000.0
DIACABS.NS,income,2023-03-31 00:00:00,Interest Income,2462000.0
DIACABS.NS,income,2023-03-31 00:00:00,Normalized Income,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Total Expenses,564534000.0
DIACABS.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,1100666.0
DIACABS.NS,income,2023-03-31 00:00:00,Diluted Average Shares,526971060.0
DIACABS.NS,income,2023-03-31 00:00:00,Basic Average Shares,526971060.0
DIACABS.NS,income,2023-03-31 00:00:00,Diluted EPS,-0.814
DIACABS.NS,income,2023-03-31 00:00:00,Basic EPS,-0.814
DIACABS.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
DIACABS.NS,income,2023-03-31 00:00:00,Net Income,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Tax Provision,0.0
DIACABS.NS,income,2023-03-31 00:00:00,Pretax Income,-428787000.0
DIACABS.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,167000.0
DIACABS.NS,income,2023-03-31 00:00:00,Special Income Charges,0.0
DIACABS.NS,income,2023-03-31 00:00:00,Other Special Charges,
DIACABS.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-4054000.0
DIACABS.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,477000.0
DIACABS.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,6039000.0
DIACABS.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,2462000.0
DIACABS.NS,income,2023-03-31 00:00:00,Operating Income,-424897000.0
DIACABS.NS,income,2023-03-31 00:00:00,Operating Expense,317713000.0
DIACABS.NS,income,2023-03-31 00:00:00,Other Operating Expenses,17384000.0
DIACABS.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,188369000.0
DIACABS.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,188369000.0
DIACABS.NS,income,2023-03-31 00:00:00,Selling General And Administration,95955000.0
DIACABS.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,1460000.0
DIACABS.NS,income,2023-03-31 00:00:00,General And Administrative Expense,94495000.0
DIACABS.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,1100666.0
DIACABS.NS,income,2023-03-31 00:00:00,Gross Profit,-107184000.0
DIACABS.NS,income,2023-03-31 00:00:00,Cost Of Revenue,246821000.0
DIACABS.NS,income,2023-03-31 00:00:00,Total Revenue,139637000.0
DIACABS.NS,income,2023-03-31 00:00:00,Operating Revenue,139637000.0
DIACABS.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Normalized EBITDA,-96991861.0
DIACABS.NS,income,2022-03-31 00:00:00,Total Unusual Items,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,157042000.0
DIACABS.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,347200.0
DIACABS.NS,income,2022-03-31 00:00:00,EBITDA,-96991861.0
DIACABS.NS,income,2022-03-31 00:00:00,EBIT,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Net Interest Income,-69194310.0
DIACABS.NS,income,2022-03-31 00:00:00,Interest Expense,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Interest Income,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Normalized Income,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Total Expenses,185339551.0
DIACABS.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Diluted Average Shares,26971067.0
DIACABS.NS,income,2022-03-31 00:00:00,Basic Average Shares,26971067.0
DIACABS.NS,income,2022-03-31 00:00:00,Diluted EPS,-9.4
DIACABS.NS,income,2022-03-31 00:00:00,Basic EPS,-9.4
DIACABS.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Net Income,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Tax Provision,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Pretax Income,-254033861.0
DIACABS.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,500000.0
DIACABS.NS,income,2022-03-31 00:00:00,Special Income Charges,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Other Special Charges,
DIACABS.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-69194310.0
DIACABS.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,69194310.0
DIACABS.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Operating Income,-185339551.0
DIACABS.NS,income,2022-03-31 00:00:00,Operating Expense,184992351.0
DIACABS.NS,income,2022-03-31 00:00:00,Other Operating Expenses,-1721713.0
DIACABS.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,157041870.0
DIACABS.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,157041870.0
DIACABS.NS,income,2022-03-31 00:00:00,Selling General And Administration,20585491.0
DIACABS.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,332288.0
DIACABS.NS,income,2022-03-31 00:00:00,General And Administrative Expense,20253203.0
DIACABS.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Gross Profit,-347200.0
DIACABS.NS,income,2022-03-31 00:00:00,Cost Of Revenue,347200.0
DIACABS.NS,income,2022-03-31 00:00:00,Total Revenue,0.0
DIACABS.NS,income,2022-03-31 00:00:00,Operating Revenue,0.0
DIACABS.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
DIACABS.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
DIACABS.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
DIACABS.NS,income,2021-03-31 00:00:00,Total Unusual Items,
DIACABS.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
DIACABS.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
DIACABS.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
DIACABS.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
DIACABS.NS,income,2021-03-31 00:00:00,EBITDA,
DIACABS.NS,income,2021-03-31 00:00:00,EBIT,
DIACABS.NS,income,2021-03-31 00:00:00,Net Interest Income,
DIACABS.NS,income,2021-03-31 00:00:00,Interest Expense,
DIACABS.NS,income,2021-03-31 00:00:00,Interest Income,0.0
DIACABS.NS,income,2021-03-31 00:00:00,Normalized Income,
DIACABS.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
DIACABS.NS,income,2021-03-31 00:00:00,Total Expenses,
DIACABS.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,0.0
DIACABS.NS,income,2021-03-31 00:00:00,Diluted Average Shares,26971067.0
DIACABS.NS,income,2021-03-31 00:00:00,Basic Average Shares,26971067.0
DIACABS.NS,income,2021-03-31 00:00:00,Diluted EPS,-8.9
DIACABS.NS,income,2021-03-31 00:00:00,Basic EPS,-8.9
DIACABS.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
DIACABS.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
DIACABS.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
DIACABS.NS,income,2021-03-31 00:00:00,Net Income,
DIACABS.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
DIACABS.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
DIACABS.NS,income,2021-03-31 00:00:00,Tax Provision,
DIACABS.NS,income,2021-03-31 00:00:00,Pretax Income,
DIACABS.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
DIACABS.NS,income,2021-03-31 00:00:00,Special Income Charges,
DIACABS.NS,income,2021-03-31 00:00:00,Other Special Charges,
DIACABS.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
DIACABS.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,62467219.0
DIACABS.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
DIACABS.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,0.0
DIACABS.NS,income,2021-03-31 00:00:00,Operating Income,
DIACABS.NS,income,2021-03-31 00:00:00,Operating Expense,
DIACABS.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
DIACABS.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
DIACABS.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
DIACABS.NS,income,2021-03-31 00:00:00,Selling General And Administration,15574715.0
DIACABS.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,0.0
DIACABS.NS,income,2021-03-31 00:00:00,General And Administrative Expense,15574715.0
DIACABS.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,0.0
DIACABS.NS,income,2021-03-31 00:00:00,Gross Profit,
DIACABS.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
DIACABS.NS,income,2021-03-31 00:00:00,Total Revenue,
DIACABS.NS,income,2021-03-31 00:00:00,Operating Revenue,
